Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Background The influence of the quality of dietary fat on some aspects of lipid metabolism-i.e. lipoprotein concentrations, post-prandial lipids and LDL size-is not completely understood, especially in healthy individuals.Objectives Aim of this study was to evaluate the effects of different types of dietary fat (monounsaturated vs. saturated fatty acids, and n-3 or placebo supplementation) on fasting lipoproteins, LDL size and post-prandial lipids in healthy people.Design One hundred and sixty-two individuals were randomly assigned to follow two isoenergetic diets, one rich in saturated fatty acids (SFA diet) and the other in monounsaturated fatty acids (MUFA diet). Each group was further randomised to receive supplementation with fish oil (3.6 g/day) or placebo.Results The type of diet significantly affected LDL cholesterol and triacylglycerol content, which was higher with the SFA diet and lower with the MUFA diet. The changes between the two diets were statistically significant for cholesterol (P<0.01) and triacylglycerol (P<0.03). VLDL cholesterol and triacylglycerol were significantly reduced and LDL cholesterol significantly increased by fish oil supplementation. Plasma triacylglycerol was significantly lower in those taking n-3 fatty acids, also 1 and 3 h after a test-meal. Neither type of diet nor n-3 supplementation affected LDL size.Conclusions A moderate substitution of saturated fatty acids with monounsaturated fatty acids has beneficial effects on lipid metabolism also in healthy individuals. A moderate supplementation of long-chain n-3 fatty acids in healthy individuals reduces both fasting and post-prandial triacylglycerol concentrations but increases LDL cholesterol, irrespective of the type of diet.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the only available RCT in patients with ASCVD, a partially purified extract of RYR reduced recurrent events by 45% [146].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [146]
In the citing paper
“In general, n-3 fatty acids have limited ( , 5%) or no effect on HDL-C levels. 156,172”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [156]
In the citing paper
“Alfa-linolenic acid (a medium chain n-3 fatty acid present in chestnuts, some vegetables and some seed oils) is less effective on TG levels.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [156]
In the citing paper
“Pharmacological doses of n-3 fatty acids (2-3 g/day) reduce TG levels up to 30%, but a higher dosage may increase LDL-C.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [156]
In the citing paper
“Long chain n-3 PUFAs also reduce the postprandial lipaemic response. 156,172”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [156]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1999) · The Lancet · doi:10.1016/s0140-6736(99)07072-5 · Cited by 3,812 · cited 1×
“Therefore, it is possible that the benefits of long-chain n-3 fatty acids on coronary mortality (DART and GISSI studies) [36,37] could be related more to the other n-3 effects*/on cardiac arrhythmia, platelet aggregation, haemostatic variables, vascular reactivity*/than to the ones on lipid metabolism.”
BackgroundBurr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials
Mensink, R. P., & Katan, M. B. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.8.911 · Cited by 1,477
Importance of n−3 fatty acids in health and disease
Connor, W. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.171s · Cited by 1,344
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Vessby, B., Uusitupa, M., Hermansen, K., Riccardi, G., Rivellese, A. A., Tapsell, L. C., Nälsén, C., Berglund, L., Louheranta, A., Rasmussen, B. M., et al. (2001) · Diabetologia · doi:10.1007/s001250051620 · Cited by 1,119 · cited 1×
“The design of the study has been reported in detail previously [15].”
MethodSelf-citationDietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies
Clarke, R., Frost, C., Collins, R., Appleby, P., & Peto, R. (1997) · BMJ · doi:10.1136/bmj.314.7074.112 · Cited by 644
Individual fatty acid effects on plasma lipids and lipoproteins: human studies
Kris-Etherton, P., & Yu, S. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1628s · Cited by 542
Dietary fat and serum lipids: an evaluation of the experimental data
Hegsted, D., Ausman, L., Johnson, J., & Dallal, G. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.6.875 · Cited by 515
Postprandial lipoproteins and progression of coronary atherosclerosis
Karpe, F., Steiner, G., Uffelman, K., Olivecrona, T., & Hamsten, A. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90085-x · Cited by 483
Research works printed but not linked: 1
- Nilsson-Ehle, 1977, Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase, Artery, 3, 194
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Self-citationMach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
“a-Linolenic acid is less effective at altering TG levels.(156,193) Recently, a significantly lower risk of ischaemic events, including CV death, was observed in patients with elevated TG levels despite the use of statins treated with 2 g of icosapent ethyl b.”
BackgroundSelf-citation2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Self-citation2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
“In general, n-3 fatty acids have limited (,5%) or no effect on HDL-C levels.(156,172) Increased carbohydrate consumption as an isocaloric substitution for fat is associated with a significant decrease in HDL-C [0.”
BackgroundSelf-citationESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Self-citation
Metadata
- Authors
- Rivellese, A. A., Maffettone, A., Vessby, B., Uusitupa, M., Hermansen, K., Berglund, L., Louheranta, A., Meyer, B. J., & Riccardi, G.
- Affiliations
- Federico II University Hospital (IT)
- Uppsala University (SE)
- University of Eastern Finland (FI)
- Aarhus University (DK)
- University of Wollongong (AU)
- Corresponding author
- Rivellese, Angela A
- ORCID
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 167
- Issue
- 1
- Pages
- 149-158
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2053686298
- Cited by
- 198
- References
- 37
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 7 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 4 · 2019: 9 · 2018: 5 · 2017: 8 · 2016: 10 · 2015: 15 · 2014: 8 · 2013: 8 · 2012: 5
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- dietary saturated fatty acids, monounsaturated fatty acids, omega-3 fatty acids, fish oil supplementation, LDL cholesterol, LDL particle size, postprandial lipemia, triglycerides, VLDL cholesterol, dietary fat quality, lipid metabolism
- MeSH terms
- Adult, Aged, Dietary Fats, Fasting, Fatty Acids, Monounsaturated, Female, Humans, Cholesterol, HDL, Lipoproteins, LDL, Male, Middle Aged, Particle Size, Probability, Reference Values, Sampling Studies, Multicenter Studies as Topic, Fatty Acids, Omega-3, Confidence Intervals, Postprandial Period, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. https://app.cochat.ai/papers/10.1016/s0021-9150(02)00424-0
- The paper
- Rivellese, A. A., Maffettone, A., Vessby, B., Uusitupa, M., Hermansen, K., Berglund, L., Louheranta, A., Meyer, B. J., & Riccardi, G. (2003). Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Atherosclerosis. https://doi.org/10.1016/s0021-9150(02)00424-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.